Starling Oncology Reports Second Quarter 2026 Financial Results and Updates Full-Year 2026 Guidance
Go back to Starling Oncology Reports Second Quarter 2026 Financial Results and Updates Full-Year 2026 Guidance| (NASDAQ: STLN) | Delayed: 6.96 +0.33 (4.98%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $6.63 | 52 Week High | $ | |||
| Open | $6.62 | 52 Week Low | $ | |||
| Day High | $7.13 | P/E | N/A | |||
| Day Low | $6.62 | EPS | $ | |||
| Volume | 3,761,728 | |||||
| TARGETS Trust XXIV 7% TARGETS with respect to the common stock of Intel Corporation (NASDAQ: TOI) | Delayed: 5.13 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $5.13 | 52 Week High | $7.47 | |||
| Open | $5.13 | 52 Week Low | $7.47 | |||
| Day High | $5.13 | P/E | N/A | |||
| Day Low | $5.13 | EPS | $0.00 | |||
| Volume | 716,095 | |||||
| (NASDAQ: TOIIW) | Delayed: 0.05 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.05 | 52 Week High | $ | |||
| Open | $0.05 | 52 Week Low | $ | |||
| Day High | $0.05 | P/E | N/A | |||
| Day Low | $0.05 | EPS | $ | |||
| Volume | 716,095 | |||||
